Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for CDNA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2014. Start Trial.
Date Value
June 30, 2026 425.60M
March 31, 2026 313.54M
December 31, 2025 303.10M
September 30, 2025 311.14M
June 30, 2025 327.37M
March 31, 2025 379.35M
December 31, 2024 378.43M
September 30, 2024 273.25M
June 30, 2024 264.67M
March 31, 2024 256.22M
December 31, 2023 261.33M
September 30, 2023 394.13M
June 30, 2023 405.21M
March 31, 2023 420.02M
December 31, 2022 430.91M
September 30, 2022 436.68M
June 30, 2022 443.55M
March 31, 2022 457.54M
December 31, 2021 465.88M
September 30, 2021 472.15M
June 30, 2021 479.84M
March 31, 2021 471.55M
December 31, 2020 277.68M
September 30, 2020 268.64M
June 30, 2020 260.77M
Date Value
March 31, 2020 101.38M
December 31, 2019 99.00M
September 30, 2019 97.54M
June 30, 2019 93.17M
March 31, 2019 95.62M
December 31, 2018 95.93M
September 30, 2018 44.39M
June 30, 2018 28.95M
March 31, 2018 33.39M
December 31, 2017 -6.134M
September 30, 2017 -0.311M
June 30, 2017 11.83M
March 31, 2017 14.63M
December 31, 2016 19.48M
September 30, 2016 36.21M
June 30, 2016 31.90M
March 31, 2016 20.46M
December 31, 2015 29.49M
September 30, 2015 33.90M
June 30, 2015 36.77M
March 31, 2015 39.47M
December 31, 2014 41.30M
September 30, 2014 41.04M
June 30, 2014 -1.466M
March 31, 2014 -16.72M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Natera, Inc. 1.821B
Caris Life Sciences, Inc. 591.73M
Myriad Genetics, Inc. 303.90M
BioRestorative Therapies, Inc. 3.026M
Exagen, Inc. 12.22M

Shareholders Equity (Quarterly) Related Metrics